![](/img/cover-not-exists.png)
P724 Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE)
Strik, A, van de Vrie, W, Bloemsaat-Minekus, J, Nurmohamed, M, Bossuyt, P, Bodelier, A, Rispens, T, van Megen, Y, D'Haens, GVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.851
Date:
January, 2018
File:
PDF, 923 KB
english, 2018